Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study

Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study

Aim: This study aimed to investigate the effects of topical liposomal clarithromycin in combination with meglumine antimoniate (Glucantime®) on cutaneous leishmaniasis (CL) lesions.Methods: This pilot, randomized, double-blinded clinical trial was conducted on patients with CL lesions. Patients were...

Full description

Bibliographic Details
Main Authors:	Atousa Hakamifard, Reza Radmehr, Fatemeh Sokhanvari, Fatemeh Sherkat, Amirali Hariri, Jaleh Varshosaz, Zabihollah Shahmoradi, Awat Feizi, Bahareh Abtahi-Naeini, Mahsa Pourmahdi-Boroujeni
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Pharmacology
Subjects:	leishmaniasis cutaneous leishmaniasis Glucantime liposomal clarithromycin clarithromycin
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1280240/full

Similar Items

Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime
by: Naghmeh Zabolinejad, et al.
Published: (2022-04-01)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

A comparative study of therapeutic effect of inter lesional injection of bleomycine and glucantime in patients infected with cutaneous leishmaniasis
by: S Saryazdi, et al.
Published: (1995-07-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy
by: Hendra Gunawan, et al.
Published: (2018-01-01)

Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis
by: Zahra Alizadeh, et al.
Published: (2023-11-01)

Calazar: Estudio de 18 pacientes en Brasil Kala-azar. Study of 18 patients in Brazil
by: Moisés Morejón García, et al.
Published: (2006-06-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

INTRAVENOUS CLARITHROMYCIN: A VALUABLE IMMUNOMODULATOR FOR SEVERE INFECTIONS
by: Leventogiannis Konstantinos, et al.
Published: (2014-04-01)

Intravenous clarithromycin: A valuable immunomodulator for severe infections
by: Leventogiannis Konstantinos, et al.
Published: (2014-01-01)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
by: Hossein Mahmoudvand, et al.
Published: (2014-12-01)

Permanent Taste and Smell Disorders Induced by Clarithromycin: A Case Report
by: Nihat Şengeze, et al.
Published: (2015-03-01)

Acute Colchicine-induced Neuromyopathy in a Patient Treated with Atorvastatin and Clarithromycin
by: José M. Olmos-Martínez, et al.
Published: (2019-03-01)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
by: Sohrab Iranpour, et al.
Published: (2019-03-01)

Visceral and cutaneous leishmaniasis in urban area of cartagena: a case report
by: Pinzón-Redondo Hernando, et al.
Published: (2012-06-01)

The Efficacy of Clarithromycin in Patients with Severe Nasal Polyposis
by: Payman Dabirmoghaddam, et al.
Published: (2013-06-01)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
by: Soheila Molaie, et al.
Published: (2019-02-01)

Clarithromycin induced psychotic disorder with catatonic-like features in an adolescent girl: Case report (eng)
by: Burcu Ersöz Alan, et al.
Published: (2022-05-01)

Effect of Clarithromycin on Enhancement of Doxorubicin-induced Cytotoxicity and Apoptosis in A549 Tumor-Cell Line
by: Mohammad Shokrzadeh, et al.
Published: (2022-10-01)

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2020-10-01)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022-04-01)

Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps
by: Thiago Freire Pinto Bezerra, et al.
Published: (2021-05-01)

Comparison of the effect of levofloxacin-based three-drug regimen with clarithromycin-based four-drug regimen in the treatment of Helicobacter pylori infection in Birjand: Short Communication
by: Fatemeh Abasnia, et al.
Published: (2021-06-01)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
by: Muhammad Israr, et al.
Published: (2022-05-01)

High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran
by: Amin T Abadi, et al.
Published: (2011-01-01)

The Efficacy of Levofloxacin versus Clarithromycin in Primary Quadruple Therapy for the Eradication of Helicobacter Pylori: A Prospective Randomized Controlled Clinical Trial Study
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
by: Farzad Khademi, et al.
Published: (2013-01-01)

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice
by: M.A. Nilforoushzadeh, et al.
Published: (2008-11-01)

Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
by: Khaled Mohammad Cheha, et al.
Published: (2018-01-01)